DOI QR코드

DOI QR Code

Diagnosis and Treatment of Premature Atrial or Ventricular Complexes

조기 수축의 진단과 치료

  • Jinhee Ahn (Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine)
  • 안진희 (부산대학교 의과대학 부산대학교병원 순환기내과)
  • Received : 2024.01.22
  • Accepted : 2024.01.25
  • Published : 2024.02.01

Abstract

Premature atrial complex (PAC) and premature ventricular complex (PVC) are the most common arrhythmias. Most of them are benign, whereas some could be an initial sign of any underlying significant heart disease. Evaluation of daily burden and the presence of any association with underlying medical conditions are essential for proper assessment. Recently, newly developed electrocardiogram smart devices are widely available to document arrhythmias and identify correlations with symptoms. Management is required if the daily burden is high, patients are highly symptomatic, or significant structural heart disease is present. Antiarrhythmic drugs (AADs) are the first-line treatment, but if arrhythmias are drug-refractory or the patients are intolerable to AADs, catheter ablation is considered a good alternative in selected cases. In this paper, the proper diagnosis and management for PAC and PVC will be comprehensively reviewed.

Keywords

Acknowledgement

This work was supported by the Clinical Research Grant from Pusan National University Hospital in 2023.

References

  1. Orini M, van Duijvenboden S, Young WJ, et al. Premature atrial and ventricular contractions detected on wearable-format electrocardiograms and prediction of cardiovascular events. Eur Heart J Digit Health 2023;4:112-118. https://doi.org/10.1093/ehjdh/ztad007
  2. Wit AL, Rosen MR. Pathophysiologic mechanisms of cardiac arrhythmias. Am Heart J 1983;106:798-811. https://doi.org/10.1016/0002-8703(83)90003-0
  3. Bagliani G, Della Rocca DG, De Ponti R, Capucci A, Padeletti M, Natale A. Ectopic beats: insights from timing and morphology. Card Electrophysiol Clin 2018;10:257-275. https://doi.org/10.1016/j.ccep.2018.02.013
  4. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm 2018;15:e190-e252. https://doi.org/10.1016/j.hrthm.2017.10.035
  5. Arnar DO, Mairesse GH, Boriani G, et al. Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace 2019;21:844-845. https://doi.org/10.1093/europace/euz046
  6. Marcus GM. Evaluation and management of premature ventricular complexes. Circulation 2020;141:1404-1418. https://doi.org/10.1161/CIRCULATIONAHA.119.042434
  7. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985;312:193-197. https://doi.org/10.1056/NEJM198501243120401
  8. Lin CY, Lin YJ, Chen YY, et al. Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome. J Am Heart Assoc 2015;4:e002192.
  9. Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. Am Heart J 2002;144:e10.
  10. Surawicz B, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009;53:976-981. https://doi.org/10.1016/j.jacc.2008.12.013
  11. Vetta G, Parlavecchio A, Caminiti R, et al. Non-conducted premature atrial complexes: a new independent predictor of atrial fibrillation in cryptogenic stroke. J Electrocardiol 2022;74:46-53. https://doi.org/10.1016/j.jelectrocard.2022.07.071
  12. Akdemir B, YarmohammadI H, Alraies MC, Adkisson WO. Premature ventricular contractions: reassure or refer? Cleve Clin J Med 2016;83:524-530. https://doi.org/10.3949/ccjm.83a.15090
  13. Vervueren PL, Delmas C, Berry M, et al. Reversal of dilated cardiomyopathy after successful radio-frequency ablation of frequent atrial premature beats, a new cause for arrhythmia-induced cardiomyopathy. J Atr Fibrillation 2012;5:627.
  14. Conen D, Adam M, Roche F, et al. Premature atrial contractions in the general population: frequency and risk factors. Circulation 2012;126:2302-2308. https://doi.org/10.1161/CIRCULATIONAHA.112.112300
  15. Jain R, Dalal D, Daly A, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation 2009;120:477-487. https://doi.org/10.1161/CIRCULATIONAHA.108.838821
  16. Freedman B, Schnabel R, Calkins H. Opportunistic electrocardiogram screening for atrial fibrillation to prevent stroke. JAMA Cardiol 2019;4:91-92. https://doi.org/10.1001/jamacardio.2018.4335
  17. Kistler PM, Roberts-Thomson KC, Haqqani HM, et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol 2006;48:1010-1017. https://doi.org/10.1016/j.jacc.2006.03.058
  18. Muser D, Tritto M, Mariani MV, et al. Diagnosis and treatment of idiopathic premature ventricular contractions: a stepwise approach based on the site of origin. Diagnostics (Basel) 2021;11:1840.
  19. Gladstone DJ, Dorian P, Spring M, et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. Stroke 2015;46:936-941. https://doi.org/10.1161/STROKEAHA.115.008714
  20. Baman TS, Lange DC, Ilg KJ, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010;7:865-869. https://doi.org/10.1016/j.hrthm.2010.03.036
  21. Loring Z, Hanna P, Pellegrini CN. Longer ambulatory ECG monitoring increases identification of clinically significant ectopy. Pacing Clin Electrophysiol 2016;39:592-597. https://doi.org/10.1111/pace.12852
  22. Steinhubl SR, Waalen J, Edwards AM, et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA 2018;320:146-155. https://doi.org/10.1001/jama.2018.8102
  23. Bacevicius J, Taparauskaite N, Kundelis R, et al. Six-lead electrocardiography compared to single-lead electrocardiography and photoplethysmography of a wrist-worn device for atrial fibrillation detection controlled by premature atrial or ventricular contractions: six is smarter than one. Front Cardiovasc Med 2023;10:1160242.
  24. Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation 2017;136:1784-1794. https://doi.org/10.1161/CIRCULATIONAHA.117.030583
  25. Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019;381:1909-1917. https://doi.org/10.1056/NEJMoa1901183
  26. von Rotz M, Aeschbacher S, Bossard M, et al. Risk factors for premature ventricular contractions in young and healthy adults. Heart 2017;103:702-707. https://doi.org/10.1136/heartjnl-2016-309632
  27. Kerola T, Dewland TA, Vittinghoff E, Heckbert SR, Stein PK, Marcus GM. Modifiable predictors of ventricular ectopy in the community. J Am Heart Assoc 2018;7:e010078.
  28. Wang Z, Qin H, Chen G, et al. Anxiety is associated with increased risk for atrial cardiopathy. Acta Neurol Belg 2020; 120:1383-1388. https://doi.org/10.1007/s13760-020-01335-0
  29. Kerola T, Dewland TA, Vittinghoff E, Heckbert SR, Stein PK, Marcus GM. Predictors of atrial ectopy and their relationship to atrial fibrillation risk. Europace 2019;21:864-870. https://doi.org/10.1093/europace/euz008
  30. Simpson RJ Jr, Cascio WE, Schreiner PJ, Crow RS, Rautaharju PM, Heiss G. Prevalence of premature ventricular contractions in a population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2002;143:535-540. https://doi.org/10.1067/mhj.2002.120298
  31. Cohen EJ, Klatsky AL, Armstrong MA. Alcohol use and supraventricular arrhythmia. Am J Cardiol 1988;62:971-973. https://doi.org/10.1016/0002-9149(88)90906-X
  32. Ahmed S, Hisamatsu T, Kadota A, et al. Premature atrial contractions and their determinants in a general population of Japanese men. Circ J 2022;86:1298-1306. https://doi.org/10.1253/circj.CJ-21-0872
  33. Dolly FR, Block AJ. Increased ventricular ectopy and sleep apnea following ethanol ingestion in COPD patients. Chest 1983;83:469-472. https://doi.org/10.1378/chest.83.3.469
  34. Wong CX, Tu SJ, Marcus GM. Alcohol and arrhythmias. JACC Clin Electrophysiol 2023;9:266-279. https://doi.org/10.1016/j.jacep.2022.10.023
  35. Dixit S, Stein PK, Dewland TA, et al. Consumption of caffeinated products and cardiac ectopy. J Am Heart Assoc 2016;5:e002503. 
  36. Marcus GM, Rosenthal DG, Nah G, et al. Acute effects of coffee consumption on health among ambulatory adults. N Engl J Med 2023;388:1092-1100. https://doi.org/10.1056/NEJMoa2204737
  37. Huang TC, Lee PT, Huang MS, Chiu PH, Su PF, Liu PY. The beneficial effects of beta blockers on the long-term prognosis of patients with premature atrial complexes. Front Cardiovasc Med 2022;9:806743.
  38. Koldenhof T, Van Gelder IC, Crijns HJGM, Rienstra M, Tieleman RG. Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial. Europace 2023;25 Suppl 1:euad122.073.
  39. Badhwar N, Scheinman MM. Idiopathic ventricular tachycardia: diagnosis and management. Curr Probl Cardiol 2007;32:7-43. https://doi.org/10.1016/j.cpcardiol.2006.10.002
  40. Abitbol H, Califano JE, Abate C, Beilis P, Castellanos H. Use of flecainide acetate in the treatment of premature ventricular contractions. Am Heart J 1983;105:227-230. https://doi.org/10.1016/0002-8703(83)90518-5
  41. Arif M, Laidlaw JC, Oshrain C, et al. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias. Angiology 1983;34:393-400. https://doi.org/10.1177/000331978303400603
  42. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med 1995;333:77-82. https://doi.org/10.1056/NEJM199507133330201
  43. Wang X, Li Z, Mao J, He B. Electrophysiological features and catheter ablation of symptomatic frequent premature atrial contractions. Europace 2017;19:1535-1541. https://doi.org/10.1093/europace/euw152
  44. Huang X, Chen Y, Xiao J, et al. Electrophysiological characteristics and catheter ablation of symptomatic focal premature atrial contractions originating from pulmonary veins and non-pulmonary veins. Clin Cardiol 2018;41:74-80. https://doi.org/10.1002/clc.22853
  45. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. https://doi.org/10.1093/eurheartj/ehac262
  46. Gulletta S, Gasperetti A, Schiavone M, et al. Long-term follow-up of catheter ablation for premature ventricular complexes in the modern era: the importance of localization and substrate. J Clin Med 2022;11:6583.
  47. Zhong L, Lee YH, Huang XM, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a single-center retrospective study. Heart Rhythm 2014;11:187-193. https://doi.org/10.1016/j.hrthm.2013.10.033
  48. Berruezo A, Penela D, Jauregui B, et al. Mortality and morbidity reduction after frequent premature ventricular complexes ablation in patients with left ventricular systolic dysfunction. Europace 2019;21:1079-1087. https://doi.org/10.1093/europace/euz027
  49. Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol 2014;114:59-64. https://doi.org/10.1016/j.amjcard.2014.04.005
  50. Prasitlumkum N, Rattanawong P, Limpruttidham N, et al. Frequent premature atrial complexes as a predictor of atrial fibrillation: systematic review and meta-analysis. J Electrocardiol 2018;51:760-767. https://doi.org/10.1016/j.jelectrocard.2018.05.012
  51. Bogun F, Crawford T, Reich S, et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm 2007;4:863-867. https://doi.org/10.1016/j.hrthm.2007.03.003
  52. Blaye-Felice MS, Hamon D, Sacher F, et al. Premature ventricular contraction-induced cardiomyopathy: related clinical and electrophysiologic parameters. Heart Rhythm 2016;13:103-110. https://doi.org/10.1016/j.hrthm.2015.08.025
  53. Pol LC, Deyell MW, Frankel DS, et al. Ventricular premature depolarization QRS duration as a new marker of risk for the development of ventricular premature depolarization-induced cardiomyopathy. Heart Rhythm 2014;11:299-306. https://doi.org/10.1016/j.hrthm.2013.10.055
  54. Viskin S, Rosso R, Rogowski O, Belhassen B. The "shortcoupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol 2005;16:912-916.  https://doi.org/10.1111/j.1540-8167.2005.50040.x